1. Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group. Issue 1 (January 2017) Authors: Fleischmann, R; Mease, PJ; Schwartzman, S; Hwang, L-J; Soma, K; Connell, CA; Takiya, L; Bananis, E Journal: Clinical rheumatology Issue: Volume 36:Issue 1(2017) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LB0003 Tofacitinib with and without methotrexate versus adalimumab with methotrexate for the treatment of rheumatoid arthritis: results from oral strategy, a phase 3b/4 randomised trial. (15th June 2017) Authors: Fleischmann, R; Mysler, E; Hall, S; Kivitz, A; Moots, R; Luo, Z; Tatulych, S; DeMasi, R; Soma, K; Zhang, R; Takiya, L; Mojcik, C; Krishnaswami, S; Menon, S; Smolen, J Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0230 The effectiveness of zoster vaccine in RA patients subsequently treated with TOFACITINIB. (15th June 2017) Authors: Winthrop, KL; Wouters, A; Choy, EH; Nduaka, C; Biswas, P; Wang, L; Hodge, J; Lazariciu, I; Soma, K; Mojcik, CF; Rigby, WFC Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0686 Major adverse cardiovascular events: risk factors in patients with ra treated with tofacitinib. (15th June 2017) Authors: Charles-Schoeman, C; Valdez, H; Soma, K; Hwang, L; DeMasi, R; Boy, M; McInnes, IB Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1034 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis. Issue 6 (14th November 2014) Authors: Boyle, D L; Soma, K; Hodge, J; Kavanaugh, A; Mandel, D; Mease, P; Shurmur, R; Singhal, A K; Wei, N; Rosengren, S; Kaplan, I; Krishnaswami, S; Luo, Z; Bradley, J; Firestein, G S Journal: Annals of the rheumatic diseases Issue: Volume 74:Issue 6(2015) Page Start: 1311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0175 Inflammation detected with modern sensitive mri analysis demonstrates that therapeutic response as early as one month predicts 12-month radiographic progression: data from a study using tofacitinib and methotrexate in methotrexate-naÏve patients with early ra. (15th June 2017) Authors: Conaghan, PG; Bowes, MA; Østergaard, M; Guillard, G; Chapman, D; Stein, A; Andrews, J; Xie, Z; Koenig, A; Soma, K; Wilkinson, B Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 268 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0185 Comparison of tofacitinib safety and efficacy in rheumatoid arthritis patients with inadequate response to conventional synthetic dmards, or to one or more biological dmards. (15th June 2017) Authors: Charles-Schoeman, C; Kremer, J; Krishnaswami, S; Soma, K; Geier, J; Zhang, R; Strengholt, S; Burmester, G Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗